We report a case of a 53-year-old man presenting with depressed alertness and severe excessive sleepiness in the setting of neurosarcoidosis. Neuroimaging demonstrated hypothalamic destruction due to sarcoidosis with a CSF hypocretin level of 0 pg/mL. The patient also experienced respiratory depression that presumably resulted from hypocretin-mediated hypothalamic dysfunction as a result of extensive diencephalic injury. This is a novel case, demonstrating both hypocretin deficiency syndrome, as well as respiratory dysfunction from destruction of hypocretin neurons and extensive destruction of key diencephalic structures secondary to the underlying neurosarcoidosis.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4543251 | PMC |
| http://dx.doi.org/10.5664/jcsm.5028 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
The Role of T Cells in the Pathogenesis of Narcolepsy Type 1: A Narrative Review.
Int J Mol Sci
November 2024
Department of Immunology, College of Basic Medicine and Forensic Medicine, Henan University of Science and Technology, Luoyang 471003, China.
Article Synopsis
- - Narcolepsy type 1 (NT1) is a rare sleep disorder characterized by excessive daytime sleepiness, cataplexy, and disruptions in REM sleep, linked to the loss of neurons that produce a wakefulness-promoting neuropeptide called orexin.
- - The condition's onset may be influenced by factors like genetic predisposition, environmental triggers, and especially an autoimmune reaction, with a noted increase in cases following certain viral infections and vaccinations.
- - Research highlights the role of specific T cells in attacking orexin-producing neurons, emphasizing the need for further understanding of NT1's autoimmune mechanisms to develop effective treatments.
Measuring energy expenditure in narcolepsy using doubly-labelled water and respiration chamber calorimetry.
Sleep
November 2024
NUTRIM School for Nutrition and Translational Research in Metabolism, Maastricht University Medical Centre, Maastricht, The Netherlands.
Article Synopsis
- Hypocretin deficiency leads to type 1 narcolepsy, which is associated with excessive daytime sleepiness and a high prevalence of overweight and obesity in patients.
- A study compared energy expenditure in ten males with narcolepsy to nine healthy controls using respiration chamber calorimetry and doubly labelled water.
- Results showed no significant differences in energy expenditure or physical activity between the two groups, suggesting that weight gain in narcolepsy might be influenced by factors other than metabolism, such as dietary habits.
Orexins mitigate obesity-associated dysfunctions in mice.
Obesity (Silver Spring)
October 2024
INSERM UMR1149/Inflammation Research Center (CRI), Université Paris Cité, Paris, France.
Objective: Obesity is a chronic disease that affects more than 400 million adults with severe comorbidities. The search for new treatments to reduce its negative consequences is necessary. Orexins are hypothalamic neuropeptides involved in various physiological processes related to obesity.
View Article and Find Full Text PDFRecent insights into the pathophysiology of narcolepsy type 1.
Sleep Med Rev
December 2024
Stichting Epilepsie Instellingen Nederland (SEIN), Sleep-Wake center, Heemstede, the Netherlands; Department of Neurology, Leiden University Medical Centre, Leiden, the Netherlands. Electronic address:
Article Synopsis
- * There's a possibility that an autoimmune process is involved, but tests for specific autoantibodies and T-cells haven't provided clear answers; other factors, like reduced hormone production in the brain, are also being considered.
- * Currently, there is no cure for NT1, and treatment focuses on managing symptoms; however, new hypocretin receptor agonists are showing promise in clinical trials, highlighting the need for better understanding and early diagnosis to improve treatment outcomes, especially in children
Alteration of motor control during rapid eye movements (REM) sleep has been extensively described in sleep disorders, in particular in isolated REM sleep behavior disorder (iRBD) and narcolepsy type 1 (NT1). NT1 is caused by the loss of orexin/hypocretin (ORX) neurons. Unlike in iRBD, the RBD comorbid symptoms of NT1 are not associated with alpha-synucleinopathies.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!